Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
NLR family pyrin domain containing 7 (**NLRP7**) is a multi-domain intracellular protein belonging to the NOD-like receptor (NLR) family, characterized by an N-terminal pyrin domain, a central NACHT domain (a type of NTPase), and C-terminal leucine rich repeats (LRRs)[1][2][3]. NLRP7 acts as an innate immune sensor and plays a crucial role in the assembly of inflammasomes, which are multi-protein complexes responsible for the activation of inflammatory cytokines and programmed cell death[2][3]. Structurally, its pyrin domain adopts a six-helix bundle death domain fold, central to protein-protein interactions necessary for initiating inflammasome signaling and cross-talk with apoptotic pathways[2][3]. Unique features of NLRP7 promote stable effector domain interactions that distinguish its signaling from related family members. Functionally, NLRP7 is essential for maintaining genomic stability during early human embryonic development by regulating alternative splicing of key genes involved in DNA damage response and homologous recombination, such as BRCA1 and RAD51[5]. Loss of NLRP7 leads to increased DNA damage, heightened apoptosis, and developmental failure, notably associated with hydatidiform mole disease and recurrent miscarriages[5][1]. NLRP7’s protein-protein interaction partners include splicing regulators (DDX39B, PRPF8, THRAP3) and PARP1, a DNA repair enzyme, implicating it in genome maintenance and RNA processing[5]. Despite its central biological roles, there are currently no known drugs that clinically target NLRP7, and no validated mechanisms of action for pharmacological modulation have been reported. NLRP7 dysfunction presents as a biomarker for genetic instability and poor outcomes in human reproduction, and therapeutic manipulation could pose developmental risks due to its essential function in genomic integrity and cell survival[5].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on NLR family pyrin domain containing 7 (NLRP7).